sond-20230930
0001819395December 312023Q3FALSESeptember 30, 20230.050.050.050.050.050.050.050.050.050.050.05.05.05.050.05http://fasb.org/us-gaap/2023#AdditionalPaidInCapital.050.0516.662516.662516.662516.662516.6616.6600018193952023-01-012023-09-300001819395us-gaap:CommonStockMember2023-01-012023-09-300001819395us-gaap:WarrantMember2023-01-012023-09-3000018193952023-11-01xbrli:shares00018193952023-09-30iso4217:USD00018193952022-12-3100018193952022-01-012022-12-31xbrli:pure00018193952023-07-012023-09-3000018193952022-07-012022-09-3000018193952022-01-012022-09-30iso4217:USDxbrli:shares00018193952021-12-3100018193952022-09-300001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2022-12-310001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2022-12-310001819395us-gaap:AdditionalPaidInCapitalMember2022-12-310001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001819395us-gaap:RetainedEarningsMember2022-12-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2023-01-012023-03-310001819395us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100018193952023-01-012023-03-310001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2023-01-012023-03-310001819395us-gaap:RetainedEarningsMember2023-01-012023-03-310001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2023-03-310001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2023-03-310001819395us-gaap:AdditionalPaidInCapitalMember2023-03-310001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001819395us-gaap:RetainedEarningsMember2023-03-3100018193952023-03-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2023-04-012023-06-300001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2023-04-012023-06-3000018193952023-04-012023-06-300001819395us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001819395us-gaap:RetainedEarningsMember2023-04-012023-06-300001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2023-06-300001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2023-06-300001819395us-gaap:AdditionalPaidInCapitalMember2023-06-300001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001819395us-gaap:RetainedEarningsMember2023-06-3000018193952023-06-300001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2023-07-012023-09-300001819395us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001819395us-gaap:RetainedEarningsMember2023-07-012023-09-300001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2023-09-300001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2023-09-300001819395us-gaap:AdditionalPaidInCapitalMember2023-09-300001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001819395us-gaap:RetainedEarningsMember2023-09-300001819395srt:ScenarioPreviouslyReportedMemberus-gaap:RedeemableConvertiblePreferredStockMember2021-12-310001819395srt:ScenarioPreviouslyReportedMemberus-gaap:ContingentConvertiblePreferredStockMember2021-12-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMembersrt:ScenarioPreviouslyReportedMember2021-12-310001819395sond:ExchangeableAAStockMemberus-gaap:CommonStockMembersrt:ScenarioPreviouslyReportedMember2021-12-310001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMembersrt:ScenarioPreviouslyReportedMember2021-12-310001819395us-gaap:AdditionalPaidInCapitalMembersrt:ScenarioPreviouslyReportedMember2021-12-310001819395us-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:ScenarioPreviouslyReportedMember2021-12-310001819395us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2021-12-310001819395srt:ScenarioPreviouslyReportedMember2021-12-310001819395srt:RestatementAdjustmentMemberus-gaap:RedeemableConvertiblePreferredStockMember2021-12-310001819395srt:RestatementAdjustmentMemberus-gaap:ContingentConvertiblePreferredStockMember2021-12-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMembersrt:RestatementAdjustmentMember2021-12-310001819395sond:ExchangeableAAStockMemberus-gaap:CommonStockMembersrt:RestatementAdjustmentMember2021-12-310001819395us-gaap:RedeemableConvertiblePreferredStockMember2021-12-310001819395us-gaap:ContingentConvertiblePreferredStockMember2021-12-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2021-12-310001819395sond:ExchangeableAAStockMemberus-gaap:CommonStockMember2021-12-310001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2021-12-310001819395us-gaap:AdditionalPaidInCapitalMember2021-12-310001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001819395us-gaap:RetainedEarningsMember2021-12-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2022-01-012022-03-310001819395us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100018193952022-01-012022-03-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMembersond:SonderLegacyWarrantsMember2022-01-012022-03-310001819395us-gaap:AdditionalPaidInCapitalMembersond:SonderLegacyWarrantsMember2022-01-012022-03-310001819395sond:SonderLegacyWarrantsMember2022-01-012022-03-310001819395us-gaap:RedeemableConvertiblePreferredStockMember2022-01-012022-03-310001819395us-gaap:ContingentConvertiblePreferredStockMember2022-01-012022-03-310001819395sond:ExchangeableAAStockMemberus-gaap:CommonStockMember2022-01-012022-03-310001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2022-01-012022-03-310001819395us-gaap:AdditionalPaidInCapitalMembersond:DelayedDrawWarrantMember2022-01-012022-03-310001819395sond:DelayedDrawWarrantMember2022-01-012022-03-310001819395us-gaap:RetainedEarningsMember2022-01-012022-03-310001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2022-03-310001819395sond:ExchangeableAAStockMemberus-gaap:CommonStockMember2022-03-310001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2022-03-310001819395us-gaap:AdditionalPaidInCapitalMember2022-03-310001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001819395us-gaap:RetainedEarningsMember2022-03-3100018193952022-03-310001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2022-04-012022-06-300001819395us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-3000018193952022-04-012022-06-300001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2022-04-012022-06-300001819395us-gaap:RetainedEarningsMember2022-04-012022-06-300001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2022-06-300001819395sond:ExchangeableAAStockMemberus-gaap:CommonStockMember2022-06-300001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2022-06-300001819395us-gaap:AdditionalPaidInCapitalMember2022-06-300001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001819395us-gaap:RetainedEarningsMember2022-06-3000018193952022-06-300001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2022-07-012022-09-300001819395us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2022-07-012022-09-300001819395us-gaap:RetainedEarningsMember2022-07-012022-09-300001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001819395us-gaap:CommonStockMemberus-gaap:CommonStockMember2022-09-300001819395sond:ExchangeableAAStockMemberus-gaap:CommonStockMember2022-09-300001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2022-09-300001819395us-gaap:AdditionalPaidInCapitalMember2022-09-300001819395us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001819395us-gaap:RetainedEarningsMember2022-09-30sond:entity00018193952023-09-200001819395us-gaap:CommonStockMember2023-09-190001819395us-gaap:CommonStockMember2023-09-200001819395sond:SpecialVotingStockMember2023-09-190001819395sond:SpecialVotingStockMember2023-09-200001819395us-gaap:FairValueMeasurementsRecurringMembersond:PublicWarrantMember2022-01-012022-09-300001819395us-gaap:FairValueMeasurementsRecurringMembersond:PublicWarrantMember2022-09-300001819395srt:ScenarioPreviouslyReportedMember2022-07-012022-09-300001819395srt:ScenarioPreviouslyReportedMember2022-01-012022-09-300001819395srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2022-07-012022-09-300001819395srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2022-01-012022-09-300001819395srt:ScenarioPreviouslyReportedMember2022-09-300001819395srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2022-09-3000018193952023-09-202023-09-200001819395us-gaap:SalesChannelDirectlyToConsumerMember2023-07-012023-09-300001819395us-gaap:SalesChannelDirectlyToConsumerMember2022-07-012022-09-300001819395us-gaap:SalesChannelDirectlyToConsumerMember2023-01-012023-09-300001819395us-gaap:SalesChannelDirectlyToConsumerMember2022-01-012022-09-300001819395us-gaap:SalesChannelThroughIntermediaryMember2023-07-012023-09-300001819395us-gaap:SalesChannelThroughIntermediaryMember2022-07-012022-09-300001819395us-gaap:SalesChannelThroughIntermediaryMember2023-01-012023-09-300001819395us-gaap:SalesChannelThroughIntermediaryMember2022-01-012022-09-300001819395sond:FirstTravelAgencyMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001819395us-gaap:RevenueFromContractWithCustomerMembersond:SecondTravelAgencyMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001819395sond:ThirdTravelAgencyMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001819395sond:FirstTravelAgencyMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001819395us-gaap:RevenueFromContractWithCustomerMembersond:SecondTravelAgencyMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001819395sond:ThirdTravelAgencyMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001819395sond:FirstTravelAgencyMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001819395us-gaap:RevenueFromContractWithCustomerMembersond:SecondTravelAgencyMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001819395sond:FirstTravelAgencyMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001819395us-gaap:RevenueFromContractWithCustomerMembersond:SecondTravelAgencyMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001819395sond:ThirdTravelAgencyMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001819395sond:FirstTravelAgencyMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001819395us-gaap:AccountsReceivableMembersond:SecondTravelAgencyMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001819395sond:FirstTravelAgencyMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001819395us-gaap:AccountsReceivableMembersond:SecondTravelAgencyMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001819395us-gaap:AccountsReceivableMembersond:ThirdTravelAgencyMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001819395sond:FourthTravelAgencyMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001819395sond:PublicWarrantMembersond:GoresMetropoulosSponsorIILLCMember2022-01-180001819395sond:PrivatePlacementWarrantMember2022-01-180001819395sond:PublicWarrantMember2022-01-180001819395sond:PrivatePlacementWarrantMember2023-09-300001819395us-gaap:CommonStockMember2022-01-182022-01-180001819395sond:RecapitalizationEarnOutSharesMember2023-01-012023-09-300001819395sond:DelayedDrawWarrantMember2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMembersond:RecapitalizationEarnOutSharesMemberus-gaap:FairValueInputsLevel1Member2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMembersond:RecapitalizationEarnOutSharesMemberus-gaap:FairValueInputsLevel3Member2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMembersond:RecapitalizationEarnOutSharesMember2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMembersond:SPACWarrantsMemberus-gaap:FairValueInputsLevel1Member2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMembersond:SPACWarrantsMemberus-gaap:FairValueInputsLevel3Member2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMembersond:SPACWarrantsMember2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMember2023-09-300001819395us-gaap:FairValueMeasurementsRecurringMembersond:RecapitalizationEarnOutSharesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMembersond:RecapitalizationEarnOutSharesMemberus-gaap:FairValueInputsLevel3Member2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMembersond:RecapitalizationEarnOutSharesMember2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMembersond:PublicWarrantMemberus-gaap:FairValueInputsLevel1Member2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMembersond:PublicWarrantMemberus-gaap:FairValueInputsLevel3Member2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMembersond:PublicWarrantMember2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membersond:PrivatePlacementWarrantMember2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Membersond:PrivatePlacementWarrantMember2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMembersond:PrivatePlacementWarrantMember2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMember2022-12-310001819395us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-09-300001819395us-gaap:FairValueMeasurementsRecurringMembersond:EarnOutLiabilityMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-09-300001819395us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001819395us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-12-310001819395us-gaap:FairValueMeasurementsRecurringMembersond:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-12-310001819395us-gaap:FairValueMeasurementsRecurringMembersond:EarnOutLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-12-310001819395us-gaap:FairValueMeasurementsRecurringMembersond:PreferredStockWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-12-3100018193952023-01-180001819395sond:DelayedDrawNotesMember2021-12-102021-12-100001819395sond:DelayedDrawWarrantMember2021-12-100001819395sond:DelayedDrawNotesMember2022-01-012022-01-310001819395sond:DelayedDrawWarrantMember2022-01-310001819395sond:DelayedDrawNotesMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-01-012022-01-310001819395sond:DelayedDrawNotesMember2023-01-012023-09-300001819395sond:DelayedDrawNotesMemberus-gaap:SubsequentEventMember2023-11-012023-11-140001819395sond:MasterEquipmentFinancingAgreementEFAMember2023-07-252023-07-250001819395sond:MasterEquipmentFinancingAgreementEFAMember2023-07-25sond:quarterly_payment0001819395sond:MasterEquipmentFinancingAgreementEFAMember2023-09-300001819395sond:ConvertiblePromissoryNoteMember2022-01-012022-01-310001819395sond:ShareSettledRedemptionFeatureMember2022-01-012022-01-310001819395sond:A2018LoanAndSecurityAgreementMemberus-gaap:SecuredDebtMember2018-12-310001819395sond:A2018LoanAndSecurityAgreementMemberus-gaap:SecuredDebtMember2022-01-012022-01-310001819395sond:A2022LoanAndSecurityAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-12-310001819395sond:A2022LoanAndSecurityAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-12-012022-12-310001819395sond:A2022LoanAndSecurityAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2023-11-130001819395sond:A2022LoanAndSecurityAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2023-11-140001819395sond:A2022LoanAndSecurityAgreementMemberus-gaap:LetterOfCreditMember2023-09-300001819395sond:A2022LoanAndSecurityAgreementMemberus-gaap:LetterOfCreditMember2022-12-310001819395us-gaap:RevolvingCreditFacilityMembersond:A2020CreditFacilityMember2020-02-290001819395us-gaap:RevolvingCreditFacilityMembersond:A2020QubecCreditFacilityMember2020-12-31iso4217:CAD0001819395us-gaap:RevolvingCreditFacilityMembersond:ConditionalRefundFinancialContributionFacilityMember2020-12-310001819395us-gaap:RevolvingCreditFacilityMembersond:A2020QubecCreditFacilityMember2020-12-012020-12-310001819395us-gaap:RevolvingCreditFacilityMembersond:ConditionalRefundFinancialContributionFacilityMember2020-12-012020-12-310001819395us-gaap:RevolvingCreditFacilityMembersond:A2020QubecCreditFacilityMember2023-09-300001819395us-gaap:RevolvingCreditFacilityMembersond:A2020QubecCreditFacilityMember2022-12-310001819395us-gaap:CostOfSalesMember2023-07-012023-09-300001819395us-gaap:CostOfSalesMember2022-07-012022-09-300001819395sond:OperatingCostsAndExpensesMember2023-07-012023-09-300001819395sond:OperatingCostsAndExpensesMember2022-07-012022-09-300001819395us-gaap:GeneralAndAdministrativeExpenseMember2023-07-012023-09-300001819395us-gaap:GeneralAndAdministrativeExpenseMember2022-07-012022-09-300001819395us-gaap:CostOfSalesMember2023-01-012023-09-300001819395us-gaap:CostOfSalesMember2022-01-012022-09-300001819395sond:OperatingCostsAndExpensesMember2023-01-012023-09-300001819395sond:OperatingCostsAndExpensesMember2022-01-012022-09-300001819395us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-09-300001819395us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-09-3000018193952022-01-180001819395sond:PostCombinationExchangeableCommonStockMember2022-01-182022-01-180001819395us-gaap:AdditionalPaidInCapitalMembersond:SonderLegacyWarrantsMember2022-01-182022-01-180001819395us-gaap:AdditionalPaidInCapitalMember2022-01-182022-01-180001819395us-gaap:AdditionalPaidInCapitalMembersond:DelayedDrawWarrantMember2022-01-182022-01-180001819395sond:PublicWarrantMember2022-12-310001819395sond:PrivatePlacementWarrantMember2022-12-310001819395sond:SPACWarrantsMember2023-01-012023-09-300001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2022-01-180001819395sond:PostCombinationExchangeableCommonStockMemberus-gaap:CommonStockMember2022-01-182022-01-180001819395sond:PostCombinationExchangeableCommonStockMember2023-09-300001819395sond:PostCombinationExchangeableCommonStockMember2022-12-310001819395sond:GeneralCommonStockMember2022-01-180001819395us-gaap:CommonStockMember2022-01-180001819395sond:SpecialVotingStockMember2022-01-180001819395sond:ExchangeableCommonStockMember2023-09-300001819395sond:ExchangeableCommonStockMember2022-12-310001819395us-gaap:EmployeeStockOptionMember2023-09-300001819395us-gaap:EmployeeStockOptionMember2022-12-310001819395us-gaap:RestrictedStockUnitsRSUMember2023-09-300001819395us-gaap:RestrictedStockUnitsRSUMember2022-12-310001819395sond:MarketStockUnitsMember2023-09-300001819395sond:MarketStockUnitsMember2022-12-310001819395us-gaap:WarrantMember2023-09-300001819395us-gaap:WarrantMember2022-12-310001819395sond:EarnOutLiabilityMember2023-09-300001819395sond:EarnOutLiabilityMember2022-12-310001819395sond:DelayedDrawNoteWarrantLiabilityMember2023-09-300001819395sond:DelayedDrawNoteWarrantLiabilityMember2022-12-310001819395us-gaap:EmployeeStockMember2023-09-300001819395us-gaap:EmployeeStockMember2022-12-310001819395sond:SonderHoldingsInc2021EquityIncentivePlanMember2023-09-300001819395sond:SonderHoldingsInc2021EquityIncentivePlanMember2022-12-310001819395sond:SonderHoldingsInc2023InducementEquityIncentivePlanMember2023-09-300001819395sond:SonderHoldingsInc2023InducementEquityIncentivePlanMember2022-12-310001819395sond:SonderHoldingsInc2021EquityIncentivePlanMemberus-gaap:EmployeeStockOptionMember2022-12-010001819395us-gaap:EmployeeStockOptionMember2022-12-012022-12-010001819395us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001819395us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-300001819395us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-09-300001819395us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-09-300001819395us-gaap:SellingAndMarketingExpenseMember2023-07-012023-09-300001819395us-gaap:SellingAndMarketingExpenseMember2022-07-012022-09-300001819395us-gaap:SellingAndMarketingExpenseMember2023-01-012023-09-300001819395us-gaap:SellingAndMarketingExpenseMember2022-01-012022-09-300001819395us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001819395us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001819395us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001819395us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001819395us-gaap:EmployeeStockOptionMembersrt:MinimumMember2023-07-012023-09-300001819395srt:MaximumMemberus-gaap:EmployeeStockOptionMember2023-07-012023-09-300001819395us-gaap:EmployeeStockOptionMembersrt:MinimumMember2023-01-012023-09-300001819395srt:MaximumMemberus-gaap:EmployeeStockOptionMember2023-01-012023-09-300001819395us-gaap:EmployeeStockOptionMembersrt:MinimumMember2022-01-012022-09-300001819395srt:MaximumMemberus-gaap:EmployeeStockOptionMember2022-01-012022-09-300001819395us-gaap:EmployeeStockOptionMembersrt:MinimumMember2022-07-012022-09-300001819395srt:MaximumMemberus-gaap:EmployeeStockOptionMember2022-07-012022-09-300001819395srt:ChiefExecutiveOfficerMember2019-11-152019-11-150001819395srt:ChiefExecutiveOfficerMembersond:PromissoryNoteMember2019-11-150001819395srt:ChiefExecutiveOfficerMembersond:A2019CEOOptionAwardMember2019-11-152019-11-15sond:installment0001819395us-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMember2019-11-152019-11-150001819395us-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMember2021-01-012021-12-310001819395us-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2019-11-152019-11-150001819395srt:ChiefExecutiveOfficerMember2021-02-182021-02-180001819395srt:ChiefExecutiveOfficerMembersond:A2021CEOOptionAwardMember2021-02-180001819395srt:ChiefExecutiveOfficerMembersond:MarketCapitalizationUnitsMember2022-12-310001819395sond:A2019And2021ServiceBasedAwardsMembersrt:ChiefExecutiveOfficerMember2019-11-150001819395sond:MarketCapitalizationUnitsMember2023-07-012023-09-300001819395sond:MarketCapitalizationUnitsMember2023-01-012023-09-300001819395sond:MarketCapitalizationUnitsMember2022-07-012022-09-300001819395sond:MarketCapitalizationUnitsMember2022-01-012022-09-300001819395us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001819395us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001819395us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-300001819395us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001819395sond:MarketStockUnitsMember2023-01-012023-09-300001819395sond:MarketStockUnitsMember2023-07-012023-09-300001819395sond:MarketStockUnitsMember2022-07-012022-09-300001819395sond:MarketStockUnitsMember2022-01-012022-09-300001819395us-gaap:ShareBasedCompensationAwardTrancheOneMembersond:MarketStockUnitsMember2023-01-012023-09-300001819395us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001819395us-gaap:ShareBasedCompensationAwardTrancheTwoMembersond:MarketStockUnitsMember2023-01-012023-09-300001819395us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001819395us-gaap:ShareBasedCompensationAwardTrancheThreeMembersond:MarketStockUnitsMember2023-01-012023-09-300001819395us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-01-012023-09-300001819395sond:ShareBasedPaymentArrangementTrancheFourMembersond:MarketStockUnitsMember2023-01-012023-09-300001819395us-gaap:RestrictedStockUnitsRSUMembersond:ShareBasedPaymentArrangementTrancheFourMember2023-01-012023-09-300001819395sond:ShareBasedPaymentArrangementTrancheFiveMembersond:MarketStockUnitsMember2023-01-012023-09-300001819395sond:ShareBasedPaymentArrangementTrancheSixMembersond:MarketStockUnitsMember2023-01-012023-09-300001819395us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001819395us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001819395us-gaap:CommonStockSubjectToMandatoryRedemptionMember2023-01-012023-09-300001819395us-gaap:CommonStockSubjectToMandatoryRedemptionMember2022-01-012022-09-300001819395us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001819395us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001819395sond:MarketStockUnitsMember2023-01-012023-09-300001819395sond:MarketStockUnitsMember2022-01-012022-09-300001819395sond:ExchangeablePreferredAndCommonStockMember2023-01-012023-09-300001819395sond:ExchangeablePreferredAndCommonStockMember2022-01-012022-09-30sond:surety_provider0001819395us-gaap:SuretyBondMember2023-09-300001819395sond:BroadStreetInvestigationMember2020-07-302020-07-300001819395sond:BroadStreetInvestigationMember2023-09-300001819395sond:BroadStreetInvestigationMember2022-12-310001819395us-gaap:CommonStockMembersond:LegacySonderMember2022-01-170001819395us-gaap:CommonStockMembersond:LegacySonderCommonStockholdersMember2022-01-182022-01-180001819395us-gaap:CommonStockMembersond:LegacySonderCommonStockholdersMember2022-01-180001819395sond:SpecialVotingSeriesAACommonStockMembersond:LegacySonderMember2022-01-180001819395sond:LegacySonderSpecialVotingCommonStockholdersMembersond:SpecialVotingSeriesAACommonStockMember2022-01-182022-01-180001819395sond:SpecialVotingSeriesAACommonStockMember2022-01-180001819395sond:LegacySonderSpecialVotingCommonStockholdersMembersond:SpecialVotingSeriesAACommonStockMember2022-01-1800018193952022-01-182022-01-180001819395us-gaap:CommonStockMembersond:LegacySonderStockOptionHoldersMember2022-01-182022-01-180001819395us-gaap:CommonStockMembersond:LegacySonderStockOptionHoldersMember2022-01-180001819395sond:NewPIPEInvestmentHoldersMember2022-01-182022-01-180001819395sond:PIPEFinancingMember2022-01-012022-09-300001819395sond:GMIIMember2022-01-012022-09-300001819395us-gaap:EmployeeSeveranceMembersond:CorporateEmployeesMember2022-06-092022-06-090001819395sond:FrontlineEmployeesMemberus-gaap:EmployeeSeveranceMember2022-06-092022-06-0900018193952022-06-092022-06-090001819395us-gaap:EmployeeSeveranceMembersond:CorporateEmployeesMember2023-03-012023-03-01
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 10-Q
___________________________________
(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
Commission file number 001-39907
___________________________________
SONDER HOLDINGS INC.
___________________________________
(Exact name of registrant as specified in its charter)
Delaware85-2097088
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
447 Sutter St. Suite 405, #542
San Francisco, California
94108
(Address of principal executive offices)(Zip Code)
(617) 300-0956
(Registrant’s telephone number, including area code)
___________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per share
SOND
The Nasdaq Stock Market LLC
Warrants, each 20 whole warrants exercisable for one share of Common Stock at an exercise price of $230.00 per share
SONDW
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes  No 
The registrant had 11,064,738 shares of common stock outstanding as of November 1, 2023.


Table of Contents
TABLE OF CONTENTS

Page

2

Table of Contents
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or our expected future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from historical experience or our present expectations.

Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements about:

•    our focus on achieving positive Free Cash Flow without additional fundraising, as part of our Cash Flow Positive Plan announced on June 9, 2022;
•    our financial, operating and growth forecasts and projections, including our focus on revenue growth rates and cost reductions, and our anticipated reductions in cash burn;
•    expectations for our business, revenue, expenses, operating results, and financial condition;
•    our lease renegotiation efforts and their potential effects on our portfolio, results of operations, and cash flow;
•    our ability to achieve or maintain profitability in the future;
•    trends in the travel and hospitality industries;
•    our pricing and revenue management strategies, pricing and occupancy forecasts and anticipated trends, and expectations about demand elasticity;
•    our expectations concerning future transaction structures and the anticipated rent, rent abatement, capital expenditure provisions, and other terms of our future leases;
•    potential ancillary revenue opportunities and our ability to improve our revenue management capabilities;
•    anticipated capital expenditure obligations, including expectations for real estate owners’ funding of capital expenditures and other pre-opening costs at our leased properties;
•    the expected adequacy of our capital resources, and the anticipated use of proceeds from any financings;
•    anticipated occupancy rates and expectations about guests’ average length of stay;
•    expectations about our geographic market mix and product mix between hotels and apartments, and their impact on our financial results;
•    expectations about employee relations and our ability to attract and retain qualified personnel;
•    our plans to roll out additional features, amenities and technologies, and our beliefs about the positive impact of our technology investments on our brand and financial results;
•    our future competitive advantages and anticipated differentiation in cost structure and guest experience compared to other accommodation providers;
•    our ability to anticipate and satisfy guest demands, including through the introduction of new features, amenities or services;
•    expectations for increased cost efficiencies and technological improvements;
•    expectations and plans for expanding in existing and new markets and accommodation categories;
•    the anticipated growth in our portfolio of units that are available for guests to book (“Live Units”) and units for which we have signed real estate contracts but which are not yet available for guests to book (“Contracted Units”), including the anticipated scope and timing of any removals of units from our portfolio;
•    expectations about our relationships with third-party distribution channels and indirect channels, and the percentage of future revenue attributable to bookings through indirect channels;
•    anticipated seasonality and other variations in our results of operations from period-to-period, including statements about anticipated Revenue per Available Room (“RevPAR”) in specified quarters;
•    trends in corporate travel and the potential for additional group and corporate travel revenue;
•    our assessments and beliefs regarding the timing and outcome of pending legal proceedings and any liability that we may incur as a result of those proceedings;
•    the anticipated effects of public health crises;
•    our assessments and estimates that determine our effective tax rate and regarding any tax-related audits or other tax proceedings; and
•    other expectations, beliefs, plans, strategies, anticipated developments, and other matters that are not historical facts.
3

Table of Contents

We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report on Form 10-Q.

You should not place undue reliance on our forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties, and other factors, many of which are beyond our control. Neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Moreover, the forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law.

For a discussion of our risk factors, see the sections entitled “Risk Factors” herein and in our most recent Annual Report on Form 10-K and subsequent SEC filings. Additional factors that could cause results or performance to materially differ from those expressed in our forward-looking statements are detailed in other filings we may make with the Securities and Exchange Commission (“SEC”), copies of which are available from us at no charge. Please consider our forward-looking statements in light of those risks as you read this report. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.


4

Table of Contents
PART I - FINANCIAL INFORMATION

Item 1. Financial Statements
SONDER HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
September 30, 2023December 31, 2022
Assets
Current assets:
Cash and cash equivalents$166,045 $246,624 
Restricted cash41,188 42,562 
Accounts receivable, net of allowance of $3,265 and $972 at September 30, 2023 and December 31, 2022, respectively
9,105 5,613 
Prepaid expenses6,388 8,066 
Other current assets10,532 10,065 
Total current assets233,258 312,930 
Property and equipment, net28,462 34,926 
Operating lease right-of-use ("ROU") assets1,439,572 1,209,486 
Other non-current assets15,045 16,270 
Total assets$1,716,337 $1,573,612 
Liabilities and stockholders’ deficit
Current liabilities:
Accounts payable$20,514 $16,082 
Accrued liabilities24,694 20,131 
Taxes payable15,894 14,418 
Deferred revenue67,819 41,664 
Current portion of long-term debt1,000  
Current operating lease liabilities199,345 158,346 
Total current liabilities329,266 250,641 
Non-current operating lease liabilities1,382,693 1,166,538 
Long-term debt, net196,398 172,950 
Other non-current liabilities668 3,430 
Total liabilities1,909,025 1,593,559 
Commitments and contingencies (Note 10)
Stockholders’ deficit:
Common stock(1)
1 1 
Additional paid-in capital(1)
972,991 947,621 
Cumulative translation adjustment10,908 12,985 
Accumulated deficit(1,176,588)(980,554)
Total stockholders’ deficit(192,688)(19,947)
Total liabilities and stockholders’ deficit$1,716,337 $1,573,612 
(1) Prior period balances have been adjusted to reflect the Reverse Stock Split (as defined in Note 1) at a ratio of 1-for-20 that became effective on September 20, 2023. See Note 1, Basis of Presentation, for details.

See accompanying notes to unaudited condensed consolidated financial statements.
5

Table of Contents
SONDER HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE LOSS
(In thousands, except per share information)
(Unaudited)
Three months ended September 30,Nine months ended September 30,
2023202220232022
Revenue$160,896 $124,526 $439,037 $326,314 
Costs and operating expenses:
Cost of revenue (excluding depreciation and amortization)110,711 76,884 295,988 229,967 
Operations and support52,137 55,586 160,502 157,856 
General and administrative27,551 33,016 90,465 101,274 
Research and development5,344 6,936 17,487 22,649 
Sales and marketing20,996 13,372 55,063 35,247 
Other operating expenses1,087  1,087  
Restructuring and other charges  2,130 4,033 
Total costs and operating expenses217,826 185,794 622,722 551,026 
Loss from operations(56,930)(61,268)(183,685)(224,712)
Interest expense, net6,423 4,112 18,285 16,696 
Change in fair value of SPAC Warrants(276)495 (674)(23,819)
Change in fair value of Earn Out Liability(209)2,223 (2,142)(94,299)
Change in fair value of share-settled redemption feature and gain on conversion of convertible notes   (29,512)
Other expense (income), net1,032 5,175 (3,759)14,050 
Total non-operating expense (income), net6,970 12,005 11,710 (116,884)
Loss before income taxes(63,900)(73,273)(195,395)(107,828)
Provision for income taxes376 416 639 564 
Net loss$(64,276)$(73,689)$(196,034)$(108,392)
Basic and diluted net loss per common share(1)
$(5.86)$(6.83)$(17.97)$(10.70)
Other comprehensive loss:
Net loss$(64,276)$(73,689)$(196,034)$(108,392)
Change in foreign currency translation adjustment3,256 4,833 (2,078)11,916 
Comprehensive loss$(61,020)$(68,856)$(198,112)$(96,476)
(1) Prior period balances have been adjusted to reflect the Reverse Stock Split (as defined in Note 1) at a ratio of 1-for-20 that became effective on September 20, 2023. See Note 1, Basis of Presentation, for details.

See accompanying notes to unaudited condensed consolidated financial statements.
6

Table of Contents
SONDER HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Nine months ended September 30,
20232022
Cash flows from operating activities:
Net loss$(196,034)$(108,392)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization18,908 17,801 
Stock-based compensation25,362 18,139 
Amortization of operating lease ROU assets130,192 105,569 
Impairment of ROU assets1,087  
(Gain) loss on foreign exchange(2,445)13,092 
Capitalization of paid-in-kind interest on long-term debt20,418 12,544 
Amortization of debt issuance costs6 149 
Amortization of debt discounts1,274 3,374 
Change in fair value of share-settled redemption feature and gain on conversion of convertible notes (29,512)
Change in fair value of SPAC Warrants(674)(23,819)
Change in fair value of Earn Out Liability(2,142)(94,299)
Other operating activities897 1,362 
Changes in:
Accounts receivable, net(4,817)(1,560)
Prepaid expenses1,885 (2,543)
Other current and non-current assets1,177 10,750 
Accounts payable4,433 (28,401)
Accrued liabilities3,911 2,295 
Taxes payable1,706 6,181 
Deferred revenue25,651 30,204 
Operating lease ROU assets and operating lease liabilities, net(105,422)(58,493)
Other current and non-current liabilities589 1,467 
Net cash used in operating activities(74,038)(124,092)

7

Table of Contents
SONDER HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(In thousands)
(Unaudited)
Nine months ended September 30,
20232022
Cash flows from investing activities:
Purchase of property and equipment(10,988)(23,579)
Capitalization of internal-use software(1,117)(2,510)
Net cash used in investing activities(12,105)(26,089)
Cash flows from financing activities:
Proceeds from Delayed Draw Notes 159,225 
Repayment of debt and payment of early termination fees(250)(27,745)
Proceeds from issuance of debt3,000  
Proceeds from business combination and PIPE Investment 325,928 
Common stock issuance costs (58,555)
Proceeds from exercise of stock options8 1,702 
Net cash provided by financing activities2,758 400,555 
Effects of foreign exchange on cash1,432 (1,860)
Net change in cash, cash equivalents, and restricted cash(81,953)248,514 
Cash, cash equivalents, and restricted cash at beginning of period289,186 69,941 
Cash, cash equivalents, and restricted cash at end of period$207,233 $318,455 
Supplemental disclosure of cash flow information:
Cash paid for income taxes $746 $488 
Cash paid for interest $1,494 $2,306 
Supplemental disclosure of non-cash investing and financing activities
Accrued purchases of property and equipment$359 $134 
ROU assets acquired$360,818 $199,875 
Conversion of convertible notes$ $159,172 
Conversion of Legacy Sonder Warrants$ $1,243 
Reclassification of liability-classified Legacy Sonder Warrants to equity$ $2,111 
Recognition of Earn Out Liability$ $(98,117)
Recognition of SPAC Warrants$ $(25,985)
Issuance of Delayed Draw Warrants$ $5,598 
Conversion of Exchangeable Stock(1)
$ $49,734 
Conversion of Redeemable Convertible Preferred Stock(1)
$ $518,760 
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents$166,045 $317,324 
Restricted cash41,188 1,131 
Cash, cash equivalents, and restricted cash at end of period$207,233 $318,455 
(1) Prior period balances have been adjusted to reflect the Reverse Stock Split (as defined in Note 1) at a ratio of 1-for-20 that became effective on September 20, 2023. See Note 1, Basis of Presentation, for details.

See accompanying notes to unaudited condensed consolidated financial statements.
8

Table of Contents
SONDER HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
Three and nine months ended September 30, 2023
(In thousands, except share information)
(Unaudited)
Common StockPost-Combination Exchangeable Common Stock
Additional
Paid-in
Capital(1)
Accumulated
Translation
Adjustment
Accumulated
Deficit
Total
Stockholders’
Deficit
Shares(1)
Amount(1)
Shares(1)
Amount
Balance at December 31, 20229,919,716 $1 1,019,460 $ $947,621 $12,985 $(980,554)$(19,947)
Exercise of common stock options463 — — — 8 — — 8 
Vesting of restricted stock units25,853 — — — — — — — 
Conversion of exchangeable stock46,525 — (46,525)— — — —  
Stock-based compensation— — — — 12,180 — — 12,180 
Components of comprehensive loss:
Net loss— — — — — — (86,431)(86,431)
Change in cumulative translation adjustment— — — — — (2,637)— (2,637)
Balance at March 31, 20239,992,557 $1 972,935 $ $959,809 $10,348 $(1,066,985)$(96,827)
Exercise of common stock options6 — — — — — — — 
Vesting of restricted stock units48,562 — — — — — — — 
Conversion of exchangeable stock9,892 — (9,892)— — — —  
Stock-based compensation— — — — 8,258 — — 8,258 
Components of comprehensive loss:
Net loss— — — — — — (45,327)(45,327)
Change in cumulative translation adjustment— — — — — (2,696)— (2,696)
Balance at June 30, 202310,051,017 $1 963,043 $ $968,067 $7,652 $(1,112,312)$(136,592)
Exercise of common stock options— — — — — — — — 
Vesting of restricted stock units2,474 — — — — — — — 
Conversion of exchangeable stock— — — — — — — — 
Stock-based compensation— — — — 4,924 — — 4,924 
Components of comprehensive loss:
Net loss— — — — — — (64,276)(64,276)
Change in cumulative translation adjustment— — — — — 3,256 — 3,256 
Balance at September 30, 202310,053,491 $1 963,043 $ $972,991 $10,908 $(1,176,588)$(192,688)
(1) Prior period balances have been adjusted to reflect the Reverse Stock Split (as defined in Note 1) at a ratio of 1-for-20 that became effective on September 20, 2023. See Note 1, Basis of Presentation, for details.

See accompanying notes to unaudited condensed consolidated financial statements.
9

Table of Contents
SONDER HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (continued)
Three and nine months ended September 30, 2022
(In thousands, except share information)
(Unaudited)

Redeemable
Convertible Preferred
Stock
Exchangeable
Preferred Stock
Common StockExchangeable
Series AA Stock
Post-Combination Exchangeable Common Stock
Additional
Paid-in
Capital(1)
Accumulated
Translation
Adjustment
Accumulated
Deficit
Total
Stockholders’
Equity (Deficit)
Shares(1)
Amount(1)
SharesAmount
Shares(1)
Amount(1)
SharesAmount
Shares(1)
Amount
Balance at December 31, 20213,788,354 $518,760 12,570,228 $49,733 434,212 $ 9,421,190 $  $ $43,107 $7,299 $(814,812)$(764,406)
Retroactive adjustment to reflect the exchange ratio due to business combination1,775,217 — 5,929,180 — 203,397 — 4,414,756 — — — — — — — 
Balance at December 31, 2021, as adjusted
5,563,571 $518,760 18,499,408 $49,733 637,609 $ 13,835,946 $  $ $43,107 $7,299 $(814,812)$(764,406)
Exercise of common stock options— — — — 18,147 — — — — — 873 — — 873 
Conversion of Legacy Sonder Warrants from liabilities to equity— — — — — — — — — — 2,111 — — 2,111 
CEO promissory note settlement— — — — (136,281)— — — — — — — — — 
Conversion of Legacy Sonder Warrants— — — — 7,761 — — — — — 1,243 — — 1,243 
Conversion of convertible note— — — — 950,855 — — — — — 159,173 — — 159,173 
Conversion of preferred stock(5,563,571)(518,760)— — 5,563,571 1 — — — — 518,760 — — 518,761 
Conversion of exchangeable stock— — (18,499,408)(49,733)— — (13,835,946)— 1,616,767 — 49,733 — — 49,733 
Issuance of common stock in connection with business combination and PIPE offering— — — — 2,192,291 — — — — — 267,362 — — 267,362 
Assumption of SPAC Warrants upon consummation of business combination— — — — — — — — — — (25,985)— — (25,985)
Earn Out Liability recognized upon consummation of business combination— — — — — — — — — — (98,117)— — (98,117)
Issuance of Delayed Draw Warrants— — — — — — — — — — 5,598 — — 5,598 
Stock-based compensation— — — — — — — — — — 6,680 — — 6,680 
Components of comprehensive loss:— — — — — — — — — — — — — 
Net income— — — — — — — — — — — — 10,963 10,963 
Change in cumulative translation adjustment— — — — — — — — — — — 1,999 — 1,999 
Balance at March 31, 2022— $— — $— 9,233,953 $1  $ 1,616,767 $ $930,538 $9,298 $(803,849)$135,988 


10

Table of Contents
SONDER HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (continued)
Three and nine months ended September 30, 2022 (continued)
(In thousands, except share information)
(Unaudited)

Redeemable
Convertible Preferred
Stock
Exchangeable
Preferred Stock
Common StockExchangeable
Series AA Stock
Post-Combination Exchangeable Common Stock
Additional
Paid-in
Capital(1)
Accumulated
Translation
Adjustment
Accumulated
Deficit
Total
Stockholders’
Equity (Deficit)
SharesAmountSharesAmount
Shares(1)
Amount(1)
SharesAmount
Shares(1)
Amount
Balance at March 31, 2022— $— — $— 9,233,953 $1  $ 1,616,767 $ $930,538 $9,298 $(803,849)$135,988 
Exercise of common stock options— — — — 18,794 — — — — — 574 — — 574 
Vesting of restricted stock units — — — — 1,487 — — — — — 57 — — 57 
Conversion of exchangeable stock— — — — 212,967 — — — (212,967)— — — — — 
Stock-based compensation— — — — — — — — — — 5,054 — — 5,054 
Components of comprehensive loss:
Net loss— — — — — — — — — — — — (45,666)(45,666)
Change in cumulative translation adjustment— — — — — — — — — — — 5,085 — 5,085 
Balance at June 30, 2022— $— — $— 9,467,201 $1  $ 1,403,800 $ $936,223 $14,383 $(849,515)$101,092 
Exercise of common stock options— — — — 7,966 — — — — — 129 — — 129 
Vesting of restricted stock units— — — — 25,187 — — — — — — — — — 
Conversion of exchangeable stock— — — — 360,151 — — — (360,151)— 1 — — 1 
Stock-based compensation— — — — — — — — — — 6,405 — — 6,405 
Components of comprehensive loss:— — — — — — — — — — — — — — 
Net loss— — — — — — — — — — — — (73,689)(73,689)
Change in cumulative translation adjustment— — — — — — — — — — — 4,833 — 4,833 
Balance at September 30, 2022— $— — $— 9,860,505 $1  $ 1,043,649 $ $942,758 $19,216 $(923,204)$38,771 

(1) Prior period balances have been adjusted to reflect the Reverse Stock Split (as defined in Note 1) at a ratio of 1-for-20 that became effective on September 20, 2023. See Note 1, Basis of Presentation, for details.

See accompanying notes to unaudited condensed consolidated financial statements.
11

Table of Contents
SONDER HOLDINGS INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
Note 1. Basis of Presentation

Nature of Operations

Sonder Holdings Inc., together with its wholly owned subsidiaries (collectively, the “Company”), provides short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company also provides accommodations to travelers through boutique hotels that are designated as Powered by Sonder properties, each with its own unique design elements and features.
On January 18, 2022, the Company consummated the previously announced business combination by and among Gores Metropoulos II, Inc. (“GMII”), two subsidiaries of GMII, and Sonder Operating Inc., a Delaware corporation formerly known as Sonder Holdings Inc. (“Legacy Sonder”) (the “Business Combination”). Refer to Note 13, Business Combination, for details of the transaction.
Basis of Financial Statement Presentation and Principles of Consolidation

The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”, “U.S. GAAP”, or “generally accepted accounting principles”). The condensed consolidated financial statements present the results of operations, financial position, and cash flows of Sonder Holdings Inc., its wholly owned subsidiaries, and one variable interest entity (“VIE”) for which it is the primary beneficiary in accordance with consolidation accounting guidance. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position at September 30, 2023 and December 31, 2022, its results of operations and comprehensive loss and stockholders’ deficit for the three and nine months ended September 30, 2023 and 2022, and cash flows for the nine months ended September 30, 2023 and 2022. The Company’s condensed consolidated results of operations and comprehensive loss and stockholders’ deficit for the three and nine months ended September 30, 2023 and cash flows for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full year.

The Company qualifies as an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012, and as a "smaller reporting company" as defined in Rule 12b-2 under the Securities Exchange Act of 1934, and, as such, may take advantage of specified reduced reporting requirements and deferred accounting standards adoption dates, and is relieved of other significant requirements that are otherwise generally applicable to other public companies.

Reverse Stock Split

On September 19, 2023, the Company filed a certificate of amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the outstanding shares of the Company’s common stock (including special voting common stock), par value $0.0001 per share, effective as of 4:01 p.m., Eastern Time, on September 20, 2023 (the “Effective Time”). As of the Effective Time, every 20 shares of the Company’s issued and outstanding common stock and every 20 shares of its issued and outstanding special voting common stock were combined into one issued and outstanding share of common stock or one issued and outstanding share of special voting common stock, respectively. The total number of authorized shares of common stock was reduced from 400,000,000 to 20,000,000, and the total number of authorized shares of special voting common stock was reduced from 40,000,000 to 2,000,000. The number of authorized shares of preferred stock remained unchanged at 250,000,000 shares, and the par value of the Company’s common stock (including special voting common stock) remained unchanged at $0.0001 per share.
12

Table of Contents

As of the Effective Time, proportional adjustments to reflect the Reverse Stock Split were also made to the number of shares of common stock issuable upon the exercise of the Company’s outstanding warrants and stock options, the number of shares issuable pursuant to outstanding restricted stock units, and the number of shares authorized and reserved for issuance pursuant to the Company’s equity incentive and employee stock purchase plans. The exercise prices and stock price targets of outstanding stock options, warrants, and equity awards were also proportionately adjusted, as applicable. Accordingly, with respect to the Company’s publicly traded warrants trading under the symbol “SONDW,” every 20 warrants outstanding immediately prior to the Reverse Stock Split became exercisable for one share of common stock at an exercise price of $230.00 per share. Proportional adjustments were also made to the number of shares issuable pursuant to the Earn Out provided for in the Company’s Agreement and Plan of Merger dated April 29, 2021, as amended, and its triggering event share prices. The outstanding Post-Combination Exchangeable Common Stock of the Company’s subsidiary, Sonder Canada Inc., were also consolidated on a 1-for-20 basis to reflect the Reverse Stock Split. Any fractional interests in the Post-Combination Exchangeable Common Stock were paid out in cash, applying the same per-share price applicable to the Company’s common stock, and fractional interests in the related shares of special voting common stock were paid out in cash with reference to their automatic redemption price as stated in the Company’s certificate of incorporation.

The effects of the Reverse Stock Split have been reflected in these condensed consolidated financial statements and the accompanying footnotes for all periods presented, which includes adjusting the description of any activity that may have been transacted on a pre-Reverse Stock Split basis.

Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company manages the credit risk associated with cash and cash equivalents by investing in lower risk money market funds and by maintaining operating accounts that are diversified among various institutions with good credit quality. The Company maintains cash accounts that, at times, exceed federally insured limits. The Company has not experienced any losses from maintaining cash accounts in excess of such limits. Management believes that it is not exposed to any significant risks on its cash and cash equivalent accounts.

Use of Estimates

The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expense during the reporting periods. Examples of where management makes estimates and assumptions included, but are not limited to, the fair value of share-based awards, estimated useful life of long-lived assets, bad-debt allowances, valuation of intellectual property and intangible assets, contingent liabilities, valuation allowance for deferred tax assets, and valuation of non-routine complex transactions, such as recognition of the Earn Out Liability and SPAC Warrants (both as defined below), among others. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates.

Reclassification

Certain amounts reported in previous condensed consolidated financial statements have been reclassified to conform to current period presentation. These reclassifications did not affect previously reported amounts of net loss, total assets, total stockholders’ deficit, net cash used in operating activities, net cash used in investing activities, or net cash provided by financing activities.

13

Table of Contents
Restatement of Previously Reported Financial Statements

Subsequent to the issuance of the Company’s unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2022, the Company identified and corrected the following:

The Company recorded $12.2 million as an adjustment to correct the initial recorded fair value of $23.7 million for the Public Warrants (as defined below) upon consummation of the Business Combination. This correction was made as a $12.2 million increase to the originally recorded additional paid-in capital and a corresponding reduction to other income in the September 30, 2022 condensed consolidated statements of operations and comprehensive loss. This adjustment, in addition to the adjustments in fair value from the date of the Business Combination to the end of the three and nine months ended September 30, 2022, resulted in net changes in fair value of $0.8 million and $12.5 million for the three and nine months ended September 30, 2022, respectively. Further, this adjustment resulted in a change in basic and diluted net loss per share from $7.00 per share as previously reported to $6.83 per share as corrected for the three months ended September 30, 2022 and from $9.00 per share as previously reported to $10.70 per share as corrected for the nine months ended September 30, 2022.

Management considers such correction to be immaterial to the previously issued condensed consolidated financial statements.

14

Table of Contents
The following table presents only those line items affected by the correction as discussed above (in thousands):

As Previously ReportedAdjustmentsAs Corrected
Statement of Operations and Comprehensive Loss
Three months ended September 30, 2022:
Change in fair value of SPAC Warrants$1,305 $(810)$495 
Total non-operating expense (income), net12,815 (810)12,005 
Loss before income taxes(74,083)810 (73,273)
Net loss(74,499)810 (73,689)
Comprehensive loss(69,666)810 (68,856)
Basic and diluted net loss per common share(1)
$(7.00)$0.17 $(6.83)
Nine months ended September 30, 2022:
Change in fair value of SPAC Warrants$(36,329)$12,510 $(23,819)
Total non-operating expense (income), net(129,394)12,510 (116,884)
Loss before income taxes(95,318)(12,510)(107,828)
Net loss(95,882)(12,510)(108,392)
Less: Net loss attributable to convertible and exchangeable preferred stockholders3,886 (3,886) 
Net loss attributable to common stockholders(91,996)(16,396)(108,392)
Comprehensive loss(83,966)(12,510)(96,476)
Basic and diluted net loss per common share(1)
$(9.00)$(1.70)$(10.70)
Statement of Stockholders' Equity
Three months ended September 30, 2022:
Net loss$(74,499)$810 $(73,689)
Accumulated Deficit(910,694)(12,510)(923,204)
Total stockholders' equity at September 30, 2022$39,131 $(360)$38,771 
Nine months ended September 30, 2022:
Assumption of SPAC Warrants upon consummation of business combination$(38,135)$12,150 $(25,985)
Net loss(95,882)(12,510)(108,392)
Additional Paid-in Capital930,608 12,150 942,758 
Accumulated Deficit(910,694)(12,510)(923,204)
Total stockholders' equity at September 30, 2022$39,131 $(360)$38,771 
Statement of Cash Flows
Cash flows from operating activities
Net loss$(95,882)$(12,510)$(108,392)
Change in fair value of SPAC Warrants(36,329)12,510 (23,819)
(1) Prior period balances have been adjusted to reflect the Reverse Stock Split (as defined in Note 1) at a ratio of 1-for-20 that became effective on September 20, 2023. See discussion above for details.
15

Table of Contents
Note 2. Recently Issued Accounting Standards

The following reflect recent accounting standards that have been adopted or are pending adoption by the Company. As discussed in Note 1, Basis of Presentation, the Company qualifies as an emerging growth company, and as such, has elected to use the extended transition period for complying with new or revised accounting standards and is not subject to the new or revised accounting standards applicable to public companies during the extended transition period. The accounting standards discussed below indicate effective dates for the Company as an emerging growth company with the extended transition period.

Recently Adopted Accounting Standards

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which has subsequently been amended by ASUs 2018-19, 2019-04, 2019-05, 2019-10, and 2019-11. The guidance changes how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The guidance replaces the current ‘incurred loss’ model with an ‘expected loss’ approach. This generally will result in the earlier recognition of allowances for losses and requires increased disclosures. ASU 2016-13 was effective for public business entities for fiscal years beginning after December 15, 2019. In November 2019, the FASB issued amended guidance which defers the effective date for emerging growth companies for fiscal years beginning after December 15, 2022, and interim periods therein. The Company adopted this guidance on January 1, 2023 using the modified retrospective basis. The adoption did not have a material impact on the Company’s condensed consolidated financial statements.

Recently Issued Accounting Standards Not Yet Adopted

The Company has not identified any recent accounting pronouncements not yet adopted that are expected to have a material impact on the Company’s financial position, results of operations, or cash flows.

Note 3. Revenue

The Company generates revenues primarily by providing accommodations to its guests. Direct revenue is generated from stays booked through Sonder.com, the Sonder app, or directly through the Company’s sales personnel. Indirect revenue is generated from stays booked through third party online travel agencies (“OTAs”).

The following table sets forth the Company’s total revenues for the periods indicated, disaggregated between direct and indirect (in thousands):
Three months ended September 30,Nine months ended September 30,
2023202220232022
Direct revenue$73,569 $60,775 $210,444 $149,010 
Indirect revenue87,327 63,751 228,593 177,304 
Total revenue$160,896 $124,526 $439,037 $326,314 

Three OTAs represented 24.0%, 14.3%, and 12.2%, respectively, of revenues for the three months ended September 30, 2023, while three OTAs represented 22.3%, 14.2%, and 11.9%, respectively, of revenues for the nine months ended September 30, 2023. Two OTAs represented 20.1% and 19.7%, respectively, of revenues for the three months ended September 30, 2022, while three OTAs represented 22.6%, 19.2%, and 10.1%, respectively, of revenues for the nine months ended September 30, 2022.

Two third-party corporate customers represented 18.4% and 12.7% of the gross accounts receivable balance at September 30, 2023, and four third-party corporate customers and OTAs represented 23.8%, 18.3%, 17.0%, and 11.8%, respectively, of the gross accounts receivable balance as of December 31, 2022.

16

Table of Contents
Note 4. Fair Value Measurement and Financial Instruments

Fair Value Hierarchy

Accounting standards require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the Company has the ability to access as of the measurement date.

Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.

Level 3: Significant unobservable inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

A financial instrument’s classification within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

SPAC Warrants

As part of the GMII initial public offering (“GMII IPO”), GMII issued 9,000,000 public warrants (the “Public Warrants”) and 5,500,000 private placement warrants (the “Private Placement Warrants”), of which, every 20 warrants are exercisable for one share of common stock at a price of $230.00 per common share (collectively, the “SPAC Warrants”).

Management has determined that the SPAC Warrants issued in the GMII IPO, which remained outstanding at consummation of the Business Combination and became exercisable for shares of the Company’s common stock, are subject to accounting treatment as a liability. At the consummation of the Business Combination and at September 30, 2023, the Company used the Public Warrants stock price to value the Public Warrants.

At consummation of the Business Combination, the Company used a Monte Carlo simulation methodology to value the Private Placement Warrants using Level 3 inputs, as the Company did not have observable inputs for the valuation. At December 31, 2022, the Company used the Black-Scholes option-pricing model to estimate the fair value of the Private Placement Warrants using Level 3 inputs. During the three months ended March 31, 2022, the Private Placement Warrants were transferred by the original holders and, in accordance with the contractual terms of the Private Placement Warrants, became Public Warrants upon transfer. As such, at September 30, 2023, the Company used the Public Warrants stock price to value all SPAC Warrants.

At September 30, 2023, the SPAC Warrants were valued at $0.02 per warrant.

Refer to Note 7, Warrants and Stockholders’ Deficit, for additional information about the SPAC Warrants.

Earn Out Liability

In addition to the consideration paid at consummation of the Business Combination, certain investors may receive their pro rata share of up to an aggregate of 725,000 additional shares of the Company’s common stock as consideration upon the common stock achieving certain benchmark share prices, as set forth in the merger agreement (the “Earn Out”). Management has determined that the Earn Out is subject to treatment as a liability (the “Earn Out Liability”).

At September 30, 2023, the Company used a Monte Carlo simulation methodology to value the Earn Out using Level 3 inputs. The key assumptions used in the Monte Carlo simulation are related to expected share-price volatility of 72.5%, expected term of 3.79 years, risk-free interest rate of 4.7%, and dividend yield of 0%. The expected volatility at September 30, 2023 was derived from the volatility of comparable public companies.

17

Table of Contents
Delayed Draw Warrants

The fair value of the Delayed Draw Warrants (as defined in Note 5, Debt) was estimated by separating the Delayed Draw Notes into the debt and warrants components and assigning a fair value to each component. The value assigned to the debt component was the estimated fair value as of the issuance date of similar debt without the warrants. The value assigned to the Delayed Draw Warrants component was estimated using the Black-Scholes option-pricing model using Level 3 inputs and was considered to be non-recurring in nature, in accordance with ASC 820, Fair Value Measurement. The warrants component was recorded as a debt discount, which is amortized using the effective interest method over the period from the date of issuance through the maturity date. Upon consummation of the Business Combination, the fair value of the Delayed Draw Warrants was $5.6 million and was included in additional paid in capital in the condensed consolidated balance sheet.

Disclosures about Fair Value of Financial Instruments

At September 30, 2023, the Earn Out Liability and SPAC Warrants liability were included in other non-current liabilities in the condensed consolidated balance sheets. The following table summarizes the Company’s Level 1, Level 2, and Level 3 financial liabilities measured at fair value on a recurring basis as of September 30, 2023 (in thousands):


Level 1Level 3Total
Earn Out Liability$ $275 $275 
SPAC Warrants231<